Expression of microsomal lanosterol 14alpha-demethylase (CYP51) in an engineered soluble monomeric form.

Biochem Biophys Res Commun

Centre for Functional Genomics and Bio-Chips, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Zaloska 4, SI-1000 Ljubljana, Slovenia.

Published: July 2008

We prepared a soluble monomeric form of bovine cytochrome P450 lanosterol 14alpha-demethylase (CYP51), which in mammals is a ubiquitously expressed membrane protein of the endoplasmic reticulum. We constructed two variants of bovine CYP51 (bCYP51) with different truncations and modifications in their N-terminal membrane-spanning domains. Both of these were expressed in Escherichia coli at levels of 500nmol/l. The protein variants were purified and tested for the solubility in the absence of detergent. Variant bCYP51-d1 exhibited approximately 10-fold better solubility over variant bCYT51-d2. The bCYP51-d1 eluted as a single peak in size-exclusion chromatography, corresponding to its monomeric form. The activity of bCYP51-d1 is similar to that of recombinant human CYP51 with a non-truncated membrane-spanning region. High solubility and low tendency to non-specific oligomer formation make bCYP51-d1 a promising candidate for successful crystallization, which may finally allow the structural determination of this important mammalian enzyme.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2008.04.157DOI Listing

Publication Analysis

Top Keywords

monomeric form
12
lanosterol 14alpha-demethylase
8
14alpha-demethylase cyp51
8
soluble monomeric
8
expression microsomal
4
microsomal lanosterol
4
cyp51
4
cyp51 engineered
4
engineered soluble
4
form prepared
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!